Company: Synairgen PLC

Synairgen is a respiratory company developing SNG001, a broad-spectrum antiviral offering potential against a range of respiratory viruses, including common cold, flu and coronaviruses, which can lead to critical illness. By delivering SNG001 directly into the lungs as an aerosol we aim to boost and/or restore the lungs’ antiviral responses to clear the virus and [...]Read More... from Senior Project Manager – Clinical See details

Synairgen is a respiratory company developing SNG001, a broad-spectrum antiviral offering potential against a range of respiratory viruses, including common cold, flu and coronaviruses, which can lead to critical illness. By delivering SNG001 directly into the lungs as an aerosol we aim to boost and/or restore the lungs’ antiviral responses to clear the virus and [...]Read More... from Clinical Research Associate II (North East of England) See details

Synairgen is a respiratory company developing SNG001, a broad-spectrum antiviral offering potential against a range of respiratory viruses, including common cold, flu and coronaviruses, which can lead to critical illness. By delivering SNG001 directly into the lungs as an aerosol we aim to boost and/or restore the lungs’ antiviral responses to clear the virus and [...]Read More... from Senior Project Manager – Clinical See details

Synairgen is a respiratory company developing SNG001, a broad-spectrum antiviral offering potential against a range of respiratory viruses, including common cold, flu and coronaviruses, which can lead to critical illness. By delivering SNG001 directly into the lungs as an aerosol we aim to boost and/or restore the lungs’ antiviral responses to clear the virus and [...]Read More... from Clinical Research Associate II (Midlands) See details